The IL-17A expression based on sample types, patient’s age, individual cancer stages, patient’s race, weight, and tumor grade from the UALCAN web server for cervical cancer and breast cancer is depicted in Fig. 6 and Supplementary Fig. 1, respectively. Here, IL17A is linked to breast cancer.